BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 16265844)

  • 1. Aggressive multimodality treatment for intra-hepatic recurrence of hepatocellular carcinoma following hepatic resection.
    Chan KM; Lee WC; Hung CF; Yu MC; Jan YY; Chen MF
    Chang Gung Med J; 2005 Aug; 28(8):543-50. PubMed ID: 16265844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Surgery-predominant comprehensive therapy for 134 patients with small hepatocellular carcinoma].
    Mo QG; Liang AM; Yang NW; Zhao YN; Yuan WP
    Ai Zheng; 2003 Feb; 22(2):189-91. PubMed ID: 12600298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrent hepatocellular carcinoma after hepatic resection: prognostic factors and long-term outcome.
    Chen WT; Chau GY; Lui WY; Tsay SH; King KL; Loong CC; Wu CW
    Eur J Surg Oncol; 2004 May; 30(4):414-20. PubMed ID: 15063895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of tumour recurrence after resection of hepatocellular carcinoma. Analysis of 97 consecutive patients.
    Tralhão JG; Dagher I; Lino T; Roudié J; Franco D
    Eur J Surg Oncol; 2007 Aug; 33(6):746-51. PubMed ID: 17188454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multimodality management of hepatocellular carcinoma larger than 10 cm.
    Mok KT; Wang BW; Lo GH; Liang HL; Liu SI; Chou NH; Tsai CC; Chen IS; Yeh MH; Chen YC
    J Am Coll Surg; 2003 Nov; 197(5):730-8. PubMed ID: 14585406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognosis of patients with intrahepatic recurrence after hepatic resection for hepatocellular carcinoma: a retrospective study.
    Kawano Y; Sasaki A; Kai S; Endo Y; Iwaki K; Uchida H; Shibata K; Ohta M; Kitano S
    Eur J Surg Oncol; 2009 Feb; 35(2):174-9. PubMed ID: 18325724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic hepatectomy for small hepatocellular carcinoma in Korea.
    Suh KS
    J Hepatobiliary Pancreat Surg; 2005; 12(5):365-70. PubMed ID: 16258804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Re-evaluation of lipiodolized transarterial chemoembolization therapy for intrahepatic recurrence of hepatocellular carcinoma after curative liver resection.
    Eguchi S; Matsumoto S; Hamasaki K; Takatsuki M; Hidaka M; Tajima Y; Sakamoto I; Kanematsu T
    J Hepatobiliary Pancreat Surg; 2008; 15(6):627-33. PubMed ID: 18987934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term outcome of resection of large hepatocellular carcinoma.
    Chen XP; Qiu FZ; Wu ZD; Zhang ZW; Huang ZY; Chen YF
    Br J Surg; 2006 May; 93(5):600-6. PubMed ID: 16607679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surgical treatment of hepatocellular carcinoma beyond Milan criteria. Results of liver resection, salvage transplantation, and primary liver transplantation.
    Facciuto ME; Koneru B; Rocca JP; Wolf DC; Kim-Schluger L; Visintainer P; Klein KM; Chun H; Marvin M; Rozenblit G; Rodriguez-Davalos M; Sheiner PA
    Ann Surg Oncol; 2008 May; 15(5):1383-91. PubMed ID: 18320284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Regional therapy to prevent recurrence after surgery in hepatocellular carcinoma].
    Sasaki Y; Imaoka S; Masutani S; Ohashi I; Iwamoto S; Nakamori S; Ohigashi H; Kameyama M; Hiratsuka M; Ishikawa O
    Gan To Kagaku Ryoho; 1992 Aug; 19(10 Suppl):1767-70. PubMed ID: 1326927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome of patients with huge hepatocellular carcinoma after primary resection and treatment of recurrent lesions.
    Lee SG; Hwang S; Jung JP; Lee YJ; Kim KH; Ahn CS
    Br J Surg; 2007 Mar; 94(3):320-6. PubMed ID: 17205495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resection of hepatocellular carcinoma: personal experience with 67 patients and long-term results.
    Khuhaprema T
    J Med Assoc Thai; 1999 Nov; 82(11):1071-8. PubMed ID: 10659539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of major hepatectomy for large hepatocellular carcinoma.
    Miyoshi A; Takahashi T; Otsuka T; Kohya N; Miyazaki K
    Hepatogastroenterology; 2009; 56(91-92):768-72. PubMed ID: 19621699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Particle embolization of recurrent hepatocellular carcinoma after hepatectomy.
    Covey AM; Maluccio MA; Schubert J; BenPorat L; Brody LA; Sofocleous CT; Getrajdman GI; Fong Y; Brown KT
    Cancer; 2006 May; 106(10):2181-9. PubMed ID: 16596622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Influence of different treatment modalities on survival of patients with two -stage resection of unresectable hepatocellular carcinoma].
    Fan J; Wu Z; Tang Z
    Zhonghua Wai Ke Za Zhi; 2001 Oct; 39(10):745-8. PubMed ID: 16201184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Solitary large hepatocellular carcinoma: a specific subtype of hepatocellular carcinoma with good outcome after hepatic resection.
    Yang LY; Fang F; Ou DP; Wu W; Zeng ZJ; Wu F
    Ann Surg; 2009 Jan; 249(1):118-23. PubMed ID: 19106686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant hepatic arterial infusion chemotherapy after radical hepatectomy for hepatocellular carcinoma--results of long-term follow-up.
    Asahara T; Itamoto T; Katayama K; Ono E; Dohi K; Nakanishi T; Kitamoto M; Azuma K; Ito K
    Hepatogastroenterology; 1999; 46(26):1042-8. PubMed ID: 10370664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvant intra-arterial iodine-131-labeled lipiodol for resectable hepatocellular carcinoma: a prospective randomized trial-update on 5-year and 10-year survival.
    Lau WY; Lai EC; Leung TW; Yu SC
    Ann Surg; 2008 Jan; 247(1):43-8. PubMed ID: 18156922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of transcatheter arterial infusion of anticancer agents with lipiodol to prevent recurrence of hepatocellular carcinoma after hepatic resection.
    Tanaka K; Shimada H; Togo S; Takahashi T; Endo I; Sekido H; Yoshida T
    Hepatogastroenterology; 1999; 46(26):1083-8. PubMed ID: 10370671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.